Immunoglobulin (Ig)G antibodies against IgE identified by basophil activation test as the putative causative agent of a serious allergic transfusion reaction: potential utility of the test as a new safety measure for allergic transfusion reactions

In most cases of allergic transfusion reactions (ATRs), the causative agents have not been identified and the mechanisms are largely unknown, with a few exceptions. The basophil activation test (BAT) was recently introduced in the field of transfusion to investigate the causal relationships between ATRs and transfusion, as well as the mechanisms behind them.

[1]  F. Hirayama,et al.  Possible Utility of the Basophil Activation Test for the Analysis of Mechanisms Involved in Allergic Transfusion Reactions. , 2018, Transfusion medicine reviews.

[2]  F. Hirayama,et al.  Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions , 2017, Transfusion.

[3]  W. Savage,et al.  Platelet proteins cause basophil histamine release through an immunoglobulin‐dependent mechanism , 2017, Transfusion.

[4]  F. Hirayama,et al.  Clinical utility of the basophil activation test for analysis of allergic transfusion reactions: a pilot study , 2017, Vox sanguinis.

[5]  F. Hirayama,et al.  Mitochondrial damage‐associated molecular patterns as potential proinflammatory mediators in post–platelet transfusion adverse effects , 2016, Transfusion.

[6]  P. Korošec,et al.  The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease , 2015, Allergy.

[7]  F. Hirayama,et al.  The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins , 2015, International Journal of Hematology.

[8]  A. Tobian,et al.  Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets , 2015, Transfusion.

[9]  M. Satake,et al.  Antibody against immunoglobulin E contained in blood components as causative factor for anaphylactic transfusion reactions , 2014, Transfusion.

[10]  T. Yonekawa,et al.  Anaphylactic transfusion reaction in homozygous haptoglobin deficiency detected by CD203c expression on basophils , 2014, Pediatric blood & cancer.

[11]  L. Ling,et al.  Allergic transfusion reaction caused by the shrimp allergen of donor blood: a case report. , 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[12]  D. MacGlashan Basophil activation testing. , 2013, The Journal of allergy and clinical immunology.

[13]  J. Schroeder,et al.  Scratching the surface of allergic transfusion reactions , 2013, Transfusion.

[14]  F. Hirayama Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment , 2012, British journal of haematology.

[15]  E. McGowan,et al.  Update on the Performance and Application of Basophil Activation Tests , 2013, Current Allergy and Asthma Reports.

[16]  O. Garraud,et al.  Platelets and cytokines: How and why? , 2012, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[17]  M. Satake,et al.  Immunoglobulin E oligomers identified in blood components activate mast cells: relevance to anaphylactic transfusion reaction , 2011, Transfusion.

[18]  J. Baumert,et al.  Anaphylaxis from passive transfer of peanut allergen in a blood product. , 2011, The New England journal of medicine.

[19]  S. Chollet-Martin,et al.  Anaphylactic reaction after methylene blue-treated plasma transfusion. , 2011, British Journal of Anaesthesia.

[20]  Mohamed Sellami,et al.  Anaphylactic shock to fresh‐frozen plasma inactivated with methylene blue , 2011, Transfusion.

[21]  D. MacGlashan Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  F. Hirayama,et al.  Application of the basophil activation test in the analysis of allergic transfusion reactions , 2009, Transfusion medicine.

[23]  M. Yamaguchi,et al.  Elevated Ca2+ influx–inducing activity toward mast cells in pretransfusion sera from patients who developed transfusion‐related adverse reactions , 2009, Transfusion.

[24]  R. Hamilton,et al.  Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. , 2008, The Journal of investigative dermatology.

[25]  C. Silliman The two-event model of transfusion-related acute lung injury , 2006, Critical care medicine.

[26]  M. Fujihara,et al.  Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions , 2003, Transfusion.

[27]  Laurence Klotz Reactions , 2002, The Lancet.

[28]  K. Tadokoro,et al.  Anaphylactic transfusion reactions in haptoglobin‐deficient patients with IgE and IgG haptoglobin antibodies , 2002, Transfusion.

[29]  M. I. Araújo,et al.  IgG anti-IgE autoantibodies in visceral leishmaniasis. , 2002, Memorias do Instituto Oswaldo Cruz.

[30]  N. Blumberg,et al.  Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion , 2001, The Lancet.

[31]  K. Tadokoro,et al.  Simple PCR detection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions. , 2000, Blood.

[32]  H. Nielsen,et al.  Bioactive substances in buffy‐coat‐derived platelet pools stored in platelet‐additive solutions , 1998, British journal of haematology.

[33]  D. Genser,et al.  IgE /Anti-IgE Immune Complexes in Sera from Patients with Crohn’s Disease Do Not Contain Food-Specific IgE , 1997, International Archives of Allergy and Immunology.

[34]  M. Wadhwa,et al.  Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays , 1996, British journal of haematology.

[35]  N. Jones,et al.  The prevalence of IgG1 and IgG4 autoantibodies to IgE in patients with allergic and non-allergic rhinitis. , 1995, Clinical otolaryngology and allied sciences.

[36]  S. Sandler,et al.  IgA anaphylactic transfusion reactions. , 1995, Transfusion medicine reviews.

[37]  D. Wylie,et al.  Severe anaphylactic reactions following transfusions of platelets to a patient with anti‐Ch , 1992, Transfusion.

[38]  J. Seibold,et al.  Anti-IgE autoantibodies in systemic sclerosis (scleroderma). , 1989, Annals of the rheumatic diseases.

[39]  A. Kaplan,et al.  Anti‐ige autoantibodies in systemic lupus erythematosus , 1988 .

[40]  A. Tsutsumi,et al.  [Anti-IgE autoantibody in patients with parasite infection]. , 1988, Arerugi = [Allergy].

[41]  A. Kaplan,et al.  Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. , 1988, The Journal of investigative dermatology.

[42]  M. Blajchman Transfusion medicine--the coming of age of a new specialty. , 1987, Transfusion medicine reviews.

[43]  T. Koike,et al.  Anti-IgE autoantibody in patients with atopic dermatitis. , 1985, Journal of immunology.

[44]  T. Yanagisawa,et al.  Anti-IgE autoantibody in patients with bronchial asthma. , 1984, Clinical and experimental immunology.

[45]  P. Pennec,et al.  Adverse Transfusion Reactions Associated with a Precipitating Anti‐C4 Antibody of Anti‐Rodgers Specificity 1 , 1984, Vox sanguinis.

[46]  O. Q. Hyder Reaction , 1973 .

[47]  G. Gleich,et al.  Anaphylactic transfusion reactions associated with anti-IgA antibody. , 1969, The New England journal of medicine.